


VectorY Revenue
Biotechnology Research • Amsterdam, North Holland, Netherlands • 51-100 Employees
VectorY revenue & valuation
| Annual revenue | $3,000,000 |
| Revenue per employee | $33,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,600,000 |
| Total funding | $138,000,000 |
Key Contacts at VectorY
Company overview
| Headquarters | Science Park, Matrix Innovation Center 408, Amsterdam, 1098 XH, NL |
| Phone number | +31202268020 |
| Website | |
| NAICS | 541714 |
| Founded | 2020 |
| Employees | 51-100 |
| Socials |
VectorY Email Formats
VectorY uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@vectorytx.com), used 62.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@vectorytx.com | 62.1% |
{first initial}.{last name} | j.doe@vectorytx.com | 32.8% |
{first initial}.{second initial}{last name} | j.odoe@vectorytx.com | 5.2% |
About VectorY
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide. Founded in August 2020, and based in the Amsterdam Science Park, VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics such as vectorized antibodies for both CNS and somatic disorders, with a special focus on muscle diseases. With R&D and manufacturing facilities in Amsterdam, VectorY develops proprietary & partnered programs based on its novel AAV-based vectorized antibody & gene therapy platform. Product candidates are based on new vector technologies, which will enable the next generation of highly scalable manufacturing processes within VectorY’s own manufacturing facilities. Our manufacturing capabilities will include a state-of-the-art multi-product GMP facility in the Netherlands, with the capability to deliver suspension based AAV viral vector manufacturing of up to 2000L for both clinical and commercial supply.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
VectorY has 33 employees across 9 departments.
Departments
Number of employees
VectorY Tech Stack
Discover the technologies and tools that power VectorY's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
JavaScript libraries
Maps
JavaScript libraries
JavaScript frameworks
Security
Analytics
Widgets
Font scripts
Development
Frequently asked questions
4.8
40,000 users



